GERM vs. IDNA ETF Comparison
Comparison of ETFMG Treatments Testing and Advancements ETF (GERM) to iShares Genomics Immunology and Healthcare ETF (IDNA)
GERM
ETFMG Treatments Testing and Advancements ETF
GERM Description
GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.
Grade (RS Rating)
Last Trade
$16.49
Average Daily Volume
1,989
Number of Holdings
*
48
* may have additional holdings in another (foreign) market
IDNA
iShares Genomics Immunology and Healthcare ETF
IDNA Description
The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.Grade (RS Rating)
Last Trade
$21.84
Average Daily Volume
36,386
Number of Holdings
*
40
* may have additional holdings in another (foreign) market
Performance
| Period | GERM | IDNA |
|---|---|---|
| 30 Days | -8.99% | -8.62% |
| 60 Days | -8.76% | -6.43% |
| 90 Days | -11.34% | -2.33% |
| 12 Months | -23.80% | -8.67% |
11 Overlapping Holdings
| Symbol | Grade | Weight in GERM | Weight in IDNA | Overlap | |
|---|---|---|---|---|---|
| ARCT | F | 2.0% | 1.0% | 1.0% | |
| BCRX | F | 2.34% | 1.28% | 1.28% | |
| BNTX | F | 6.1% | 3.19% | 3.19% | |
| CVAC | F | 1.57% | 0.34% | 0.34% | |
| DVAX | D | 3.71% | 1.94% | 1.94% | |
| GILD | F | 0.81% | 3.22% | 0.81% | |
| MRK | B | 0.83% | 4.44% | 0.83% | |
| MRNA | A | 7.29% | 4.88% | 4.88% | |
| NVAX | F | 1.46% | 0.6% | 0.6% | |
| REGN | C | 0.81% | 4.11% | 0.81% | |
| VIR | F | 3.04% | 1.02% | 1.02% |
GERM Overweight 37 Positions Relative to IDNA
| Symbol | Grade | Weight | |
|---|---|---|---|
| DGX | C | 6.41% | |
| ALNY | F | 6.22% | |
| LH | F | 5.87% | |
| BIO | F | 4.19% | |
| PCVX | D | 3.51% | |
| IMCR | D | 3.47% | |
| ZLAB | F | 3.07% | |
| OPK | C | 2.52% | |
| HLVX | F | 1.66% | |
| SIGA | A | 1.56% | |
| FLGT | F | 1.53% | |
| ABUS | B | 1.19% | |
| ALT | D | 1.07% | |
| OCGN | B | 1.04% | |
| OSUR | F | 1.03% | |
| ADPT | F | 1.0% | |
| RENB | F | 0.95% | |
| AZN | A | 0.89% | |
| ENTA | C | 0.84% | |
| LLY | C | 0.84% | |
| PFE | F | 0.84% | |
| SNY | D | 0.83% | |
| GSK | C | 0.82% | |
| ABBV | C | 0.81% | |
| JNJ | F | 0.79% | |
| ABT | D | 0.79% | |
| TAK | F | 0.78% | |
| XBIT | A | 0.67% | |
| CRMD | A | 0.62% | |
| VXRT | F | 0.41% | |
| EBS | F | 0.28% | |
| IFRX | F | 0.23% | |
| CVM | F | 0.22% | |
| GRTS | F | 0.22% | |
| CMRX | F | 0.21% | |
| CUE | F | 0.2% | |
| VAXX | F | 0.19% |
GERM Underweight 29 Positions Relative to IDNA
| Symbol | Grade | Weight | |
|---|---|---|---|
| RVMD | A | -5.56% | |
| SRPT | D | -5.37% | |
| EXEL | A | -3.76% | |
| INCY | F | -3.7% | |
| IOVA | D | -3.29% | |
| BGNE | F | -2.85% | |
| SWTX | D | -2.69% | |
| ACLX | D | -2.67% | |
| BEAM | F | -2.35% | |
| TWST | D | -2.28% | |
| GERN | A | -2.17% | |
| DNA | F | -1.74% | |
| LGND | B | -1.69% | |
| MGNX | B | -1.36% | |
| FDMT | D | -1.25% | |
| BPMC | A | -1.24% | |
| ABCL | F | -1.1% | |
| CRSP | F | -1.08% | |
| RCUS | F | -1.05% | |
| IBRX | B | -1.0% | |
| NRIX | A | -0.96% | |
| DCPH | D | -0.94% | |
| EDIT | F | -0.67% | |
| OABI | F | -0.62% | |
| VALN | C | -0.56% | |
| NTLA | F | -0.49% | |
| CRBU | F | -0.4% | |
| QURE | F | -0.27% | |
| XNCR | F | -0.27% |
GERM: Top Represented Industries & Keywords
IDNA: Top Represented Industries & Keywords
Compare ETFs
